2022 Q4 Form 10-K Financial Statement

#000121390023016333 Filed on March 02, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2022
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue $280.0K
YoY Change -66.27%
Gross Profit $310.0K
YoY Change -75.59%
Gross Profit Margin
Selling, General & Admin $3.988M $5.916M
YoY Change 1473.57% 748.63%
% of Gross Profit 1908.39%
Research & Development $18.95M
YoY Change 87.44%
% of Gross Profit 6112.9%
Depreciation & Amortization $6.630M $13.17M
YoY Change 3.38%
% of Gross Profit 4248.39%
Operating Expenses $3.988M $5.916M
YoY Change 1473.57% 748.63%
Operating Profit -$5.916M
YoY Change -1132.7%
Interest Expense -$14.76M $10.14M
YoY Change -807.59% -250.85%
% of Operating Profit
Other Income/Expense, Net $0.00 $25.00K
YoY Change -101.15%
Pretax Income -$18.74M $4.228M
YoY Change -1123.12% -141.49%
Income Tax $0.00
% Of Pretax Income 0.0%
Net Earnings -$18.02M $4.065M
YoY Change -1123.12% -141.49%
Net Earnings / Revenue
Basic Earnings Per Share -$14.79
Diluted Earnings Per Share -$0.42 $0.09
COMMON SHARES
Basic Shares Outstanding 3.703M shares
Diluted Shares Outstanding 3.703M shares

Balance Sheet

Concept 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.628M $1.628M
YoY Change -36.67% -36.67%
Cash & Equivalents $1.628M
Short-Term Investments
Other Short-Term Assets $272.6K $272.6K
YoY Change -63.5% -63.5%
Inventory
Prepaid Expenses $272.5K
Receivables $352.0K $400.0K
Other Receivables $7.960K $0.00
Total Short-Term Assets $1.908M $1.908M
YoY Change -42.61% -42.61%
LONG-TERM ASSETS
Property, Plant & Equipment $69.60M $70.40M
YoY Change -12.44%
Goodwill $0.00
YoY Change
Intangibles $5.000M
YoY Change
Long-Term Investments
YoY Change
Other Assets $349.9M $349.9M
YoY Change 1.42% 1.42%
Total Long-Term Assets $349.9M $349.9M
YoY Change 1.42% 1.42%
TOTAL ASSETS
Total Short-Term Assets $1.908M $1.908M
Total Long-Term Assets $349.9M $349.9M
Total Assets $351.9M $351.9M
YoY Change 1.0% 1.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $31.78K $31.78K
YoY Change -77.84% -77.84%
Accrued Expenses $4.987M $4.987M
YoY Change 1226.58% 1226.57%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.019M $5.019M
YoY Change 866.38% 866.38%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $36.55M $36.55M
YoY Change -12.55% -12.55%
Total Long-Term Liabilities $36.55M $36.55M
YoY Change -12.55% -12.55%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.019M $5.019M
Total Long-Term Liabilities $36.55M $36.55M
Total Liabilities $41.57M $41.34M
YoY Change -1.76% -1.39%
SHAREHOLDERS EQUITY
Retained Earnings -$39.31M
YoY Change 1.95%
Common Stock $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$39.31M $310.5M
YoY Change
Total Liabilities & Shareholders Equity $351.9M $351.9M
YoY Change 1.0% 1.0%

Cashflow Statement

Concept 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$18.02M $4.065M
YoY Change -1123.12% -141.49%
Depreciation, Depletion And Amortization $6.630M $13.17M
YoY Change 3.38%
Cash From Operating Activities -$381.6K -$857.5K
YoY Change 429.98% -35.63%
INVESTING ACTIVITIES
Capital Expenditures $120.0K $120.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00 $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $10.00M
YoY Change
Cash From Financing Activities 0.000 -$85.00K
YoY Change -100.0% -100.02%
NET CHANGE
Cash From Operating Activities -381.6K -$857.5K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 0.000 -$85.00K
Net Change In Cash -381.6K -$942.5K
YoY Change 59.96% -136.67%
FREE CASH FLOW
Cash From Operating Activities -$381.6K -$857.5K
Capital Expenditures $120.0K $120.0K
Free Cash Flow -$501.6K -$977.5K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Interest Costs Incurred
InterestCostsIncurred
65000 usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity Registrant Name
EntityRegistrantName
RICE ACQUISITION CORP. II
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
CY2022 dei Entity File Number
EntityFileNumber
001-40503
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1580612
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
102 East Main Street
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Second Story Carnegie
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Pennsylvania
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
15106
CY2022 dei City Area Code
CityAreaCode
(713)
CY2022 dei Local Phone Number
LocalPhoneNumber
446-6259
CY2022 dei Security12b Title
Security12bTitle
Class A ordinary shares, par value $0.0001 per share
CY2022 dei Trading Symbol
TradingSymbol
RONI
CY2022 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
true
CY2022Q2 dei Entity Public Float
EntityPublicFloat
336700000 usd
CY2022 dei Auditor Name
AuditorName
WithumSmith+Brown, PC
CY2022 dei Auditor Location
AuditorLocation
New York
CY2022 dei Auditor Firm
AuditorFirmId
100
CY2022Q4 us-gaap Cash
Cash
1627877 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
746720 usd
CY2021Q4 us-gaap Cash
Cash
2570409 usd
CY2022Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
7960 usd
CY2021Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
7960 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
272546 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1908383 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
3325089 usd
CY2022Q4 us-gaap Assets Held In Trust
AssetsHeldInTrust
349942773 usd
CY2021Q4 us-gaap Assets Held In Trust
AssetsHeldInTrust
345044341 usd
CY2022Q4 us-gaap Assets
Assets
351851156 usd
CY2021Q4 us-gaap Assets
Assets
348369430 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
31780 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
143405 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4986852 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
375918 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5018632 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
519323 usd
CY2022Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
11721500 usd
CY2021Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
11721500 usd
CY2022Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
24832440 usd
CY2021Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
30077750 usd
CY2022Q4 us-gaap Liabilities
Liabilities
41572572 usd
CY2021Q4 us-gaap Liabilities
Liabilities
42318573 usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
349816773 usd
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
345000000 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 roni Common Stock Value1
CommonStockValue1
863 usd
CY2021Q4 roni Common Stock Value1
CommonStockValue1
863 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-39310765 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-38559114 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-39309902 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-38558251 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
-228287 usd
CY2021Q4 us-gaap Minority Interest
MinorityInterest
-390892 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-39538189 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-38949143 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
351851156 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
348369430 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5796015 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
632131 usd
CY2022 roni General And Administrative Expenses Related Party
GeneralAndAdministrativeExpensesRelatedParty
120000 usd
roni General And Administrative Expenses Related Party
GeneralAndAdministrativeExpensesRelatedParty
65000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-5916015 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-697131 usd
CY2022 roni Change In Fair Value Of Derivative Warrant Liabilities
ChangeInFairValueOfDerivativeWarrantLiabilities
5245310 usd
roni Change In Fair Value Of Derivative Warrant Liabilities
ChangeInFairValueOfDerivativeWarrantLiabilities
-6742750 usd
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
4898432 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
18341 usd
roni Financing Costs
FinancingCosts
592641 usd
roni Gain Loss On Issuance Of Private Warrants
GainLossOnIssuanceOfPrivateWarrants
-2175000 usd
CY2022 us-gaap Profit Loss
ProfitLoss
4227727 usd
us-gaap Profit Loss
ProfitLoss
-10189181 usd
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
162605 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-391892 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
4065122 usd
us-gaap Net Income Loss
NetIncomeLoss
-9797289 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000 usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
1000 usd
us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
28785962 usd
us-gaap Profit Loss
ProfitLoss
-10189181 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-38949143 usd
CY2022 roni Increase In Redemption Value Of Ordinary Shares Subject To Redemption
IncreaseInRedemptionValueOfOrdinarySharesSubjectToRedemption
4816773 usd
CY2022 us-gaap Profit Loss
ProfitLoss
4227727 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-39538189 usd
CY2022 us-gaap Profit Loss
ProfitLoss
4227727 usd
us-gaap Profit Loss
ProfitLoss
-10189181 usd
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
26000 usd
us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
9360 usd
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-5245310 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
6742750 usd
CY2022 us-gaap Interest Income Other
InterestIncomeOther
4898432 usd
us-gaap Interest Income Other
InterestIncomeOther
18341 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
2175000 usd
roni Offering Costs Associated With Warrants
OfferingCostsAssociatedWithWarrants
592641 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-7960 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-474174 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
746720 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-26625 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
58405 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4610934 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
25918 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-857532 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1332128 usd
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
345026000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-345026000 usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
345000000 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
10900000 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
166587 usd
CY2022 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
85000 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
6804876 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-85000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
348928537 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-942532 usd
CY2021Q2 roni Generating Gross Proceeds
GeneratingGrossProceeds
345000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
2570409 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2570409 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1627877 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2570409 usd
roni Offering Costs Included In Accrued Expenses
OfferingCostsIncludedInAccruedExpenses
350000 usd
roni Offering Costs Paid By Related Party Under Promissory Note
OfferingCostsPaidByRelatedPartyUnderPromissoryNote
157227 usd
roni Deferred Underwriting Commission
DeferredUnderwritingCommission
11721500 usd
CY2021Q2 roni Incurring Offering Costs
IncurringOfferingCosts
19100000 usd
CY2021Q2 roni Deferred Underwriting Commissions
DeferredUnderwritingCommissions
11700000 usd
CY2021Q2 roni Offering Costs Allocated
OfferingCostsAllocated
593000 usd
CY2022 roni Percentage Of Fair Market Value
PercentageOfFairMarketValue
0.80 pure
CY2022Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0.0001
CY2022Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
10
CY2022Q4 us-gaap Assets Net
AssetsNet
5000001 usd
CY2022 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
100000 usd
CY2022 roni Business Combination Agreement Description
BusinessCombinationAgreementDescription
RONI will change its jurisdiction of incorporation by deregistering as a Cayman Islands exempted company and continuing and domesticating as a corporation incorporated under the laws of the State of Delaware, upon which (a) RONI will change its name to “NET Power Inc.” (the “combined company”), (b) each then issued and outstanding Class A ordinary share of a par value $0.0001 each in the capital of RONI will convert automatically, on a one-for-one basis, to a share of Class A common stock, par value $0.0001 per share, of RONI (“Class A Common Stock”), (c) each then issued and outstanding Class B ordinary share of a par value $0.0001 each in the capital of RONI will convert automatically, on a one-for-one basis, to a share of Class B common stock, par value $0.0001 per share, of RONI (“Class B Common Stock”), and (d) each issued and outstanding warrant to purchase one Class A ordinary share in the capital of RONI at a price of $11.50 per share will convert automatically, on a one-for-one basis, into a whole warrant exercisable for one share of Class A Common Stock;
CY2022 roni Aggregate Share
AggregateShare
135698078 shares
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5000001 usd
CY2022Q4 roni Aggregate Amount
AggregateAmount
200000000 usd
CY2022Q4 roni Operating Bank Amount
OperatingBankAmount
1600000 usd
CY2022Q4 roni Working Capital Deficit
WorkingCapitalDeficit
3100000 usd
CY2022 us-gaap Other Expenses
OtherExpenses
25000 usd
CY2022 roni Sponsor Pursuant
SponsorPursuant
126000 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentration of Credit Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. As of December 31, 2022 and 2021, the Company had not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2022Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
5000001 usd
CY2022Q4 us-gaap Shares Issued
SharesIssued
19525000 shares
CY2021Q2 roni Initial Public Offering Description1
InitialPublicOfferingDescription1
the Company consummated its Initial Public Offering of 34,500,000 Units, which included the full exercise of the underwriters’ option to purchase an additional 4,500,000 Units to cover over-allotments, at $10.00 per Unit, generating gross proceeds of $345.0 million, and incurring offering costs of approximately $19.1 million, of which approximately $11.7 million and approximately $593,000 were for deferred underwriting commissions and offering costs allocated to the derivative warrant liabilities, respectively. Of the 34,500,000 Units sold, affiliates of Rice Investment Group had purchased 1,010,000 Units (the “Affiliated Units”) at the Initial Public Offering price. The underwriters did not receive any underwriting discounts or commissions on the 1,010,000 Affiliated Units.
CY2021Q1 roni Founder Shares And Sponsor Shares Description
FounderSharesAndSponsorSharesDescription
the Sponsor received 7,187,500 Class B Units of Opco for no consideration and purchased 7,187,600 of the Company’s Class B ordinary shares, par value $0.0001, 2,500 of the Company’s Class A ordinary shares and 100 Class A Units of Opco for aggregate consideration of $26,000. Of the aggregate consideration, Opco received $1,000 for the Class A Units and the Company received $25,000 for the Class A ordinary shares and the Class B ordinary shares. The Company then subscribed for 2,500 Class A Units of Opco for $25,000.
CY2021Q2 roni Founder Shares And Sponsor Shares Description
FounderSharesAndSponsorSharesDescription
the Sponsor forfeited 90,000 Class B Units of Opco, and 30,000 Class B Units of Opco were issued to each of the Company’s independent director nominees. The Sponsor transferred a corresponding number of shares of the Company’s Class B ordinary shares to the Company’s independent director nominees. In June 2021, the Company effected a dividend, and Opco effected a distribution, resulting in an aggregate of 8,625,000 Class B ordinary shares and 8,624,900 Class B Units of Opco outstanding, of which the Sponsor owned 8,535,000 of the Company’s Class B ordinary shares and 8,534,900 Class B Units of Opco.
CY2022 roni Sponsor Shares Description
SponsorSharesDescription
The Company refers to the 8,624,900 Class B ordinary shares and corresponding number of Class B Units of Opco (or the Class A Units of Opco into which such Class B Units will convert) collectively as the “Founder Shares”. The Founder Shares consist of Class B Units of Opco (and any Class A Units of Opco into which such Class B Units are converted) and a corresponding number of Class B ordinary shares, which together will be exchangeable for shares of the Company’s Class A ordinary shares after the time of the initial Business Combination on a one-for-one basis, subject to adjustment as provided herein. The Company refers to the 2,500 Class A ordinary shares and the 100 Class A Units of Opco and a corresponding number of shares of the Company’s non-economic Class B ordinary shares (which together will be exchangeable into Class A ordinary shares after the initial Business Combination on a one-for-one basis) collectively as the “Sponsor Shares”.
CY2022 roni Outstanding Shares Percentage
OutstandingSharesPercentage
0.20 pure
CY2021Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
167000 usd
CY2022 roni Working Capital Loans
WorkingCapitalLoans
1500000 usd
CY2022Q4 roni Price Per Warrant
PricePerWarrant
1
CY2021Q2 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
10000 usd
CY2022 us-gaap Interest Costs Incurred
InterestCostsIncurred
120000 usd
CY2022Q4 roni Founder Shares Aggregate Percentage
FounderSharesAggregatePercentage
0.20 pure
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 roni Exercise Price Per Share
ExercisePricePerShare
11.5
CY2022 roni Expire Year
ExpireYear
P5Y
CY2022Q4 roni Additional Units Purchased
AdditionalUnitsPurchased
4500000 shares
CY2022 roni Affiliated Units
AffiliatedUnits
1010000 shares
CY2022 roni Underwriting Discount
UnderwritingDiscount
0.2
CY2022Q4 us-gaap Share Price
SharePrice
0.35
CY2022 us-gaap Other Underwriting Expense
OtherUnderwritingExpense
11700000 usd
us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
345000000 usd
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
10260000 usd
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
-18525962 usd
roni Accretion On Class A Ordinary Shares Subject To Possible Redemption Amount
AccretionOnClassAOrdinarySharesSubjectToPossibleRedemptionAmount
28785962 usd
roni Ordinary Shares Subject To Possible Redemption
OrdinarySharesSubjectToPossibleRedemption
345000000 usd
CY2022 roni Increase In Redemption Value Of Class A Ordinary Shares Subject To Redemption
IncreaseInRedemptionValueOfClassAOrdinarySharesSubjectToRedemption
4816773 usd
CY2022 roni Ordinary Shares Subject To Possible Redemption
OrdinarySharesSubjectToPossibleRedemption
349816773 usd
CY2022Q4 roni Percentage Of Exercise Price Of Warrants Adjusted
PercentageOfExercisePriceOfWarrantsAdjusted
1.15 pure
CY2022 us-gaap Warrant Exercise Price Increase
WarrantExercisePriceIncrease
0.01
CY2022 roni Ordinary Shares Equals Or Exceeds Per Share
OrdinarySharesEqualsOrExceedsPerShare
10
CY2022 roni Increase In Fair Value Of Derivative Warrant Liabilities
IncreaseInFairValueOfDerivativeWarrantLiabilities
5200000 usd
roni Increase In Fair Value Of Derivative Warrant Liabilities
IncreaseInFairValueOfDerivativeWarrantLiabilities
6700000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
11.5
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
11.5
CY2022Q4 roni Stock Pricein Dollars Per Share
StockPriceinDollarsPerShare
10.17
CY2021Q4 roni Stock Pricein Dollars Per Share
StockPriceinDollarsPerShare
10
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.1036 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.2182 pure
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y3M29D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y5M15D
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0395 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.013 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
roni Issuance Of Public And Private Warrants
IssuanceOfPublicAndPrivateWarrants
21160000 usd
roni Loss Upon Issuance Of Private Warrants
LossUponIssuanceOfPrivateWarrants
2175000 usd
roni Transfer Of Public Warrants To Level1
TransferOfPublicWarrantsToLevel1
-11471250 usd
roni Change In Fair Value Of Derivatives Warrant Liabilities
ChangeInFairValueOfDerivativesWarrantLiabilities
5276500 usd
CY2021Q4 us-gaap Derivative Instruments And Hedges Liabilities
DerivativeInstrumentsAndHedgesLiabilities
17140250 usd
CY2022 roni Change In Fair Value Of Derivatives Warrant Liabilities
ChangeInFairValueOfDerivativesWarrantLiabilities
-3089060 usd
CY2022Q4 us-gaap Derivative Instruments And Hedges Liabilities
DerivativeInstrumentsAndHedgesLiabilities
14051190 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
CY2022 roni Financing Costs
FinancingCosts
usd
CY2022 roni Gain Loss On Issuance Of Private Warrants
GainLossOnIssuanceOfPrivateWarrants
usd
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
usd
CY2021Q1 us-gaap Derivative Instruments And Hedges Liabilities
DerivativeInstrumentsAndHedgesLiabilities
usd
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001845437

Files In Submission

Name View Source Status
0001213900-23-016333-index-headers.html Edgar Link pending
0001213900-23-016333-index.html Edgar Link pending
0001213900-23-016333.txt Edgar Link pending
0001213900-23-016333-xbrl.zip Edgar Link pending
f10k2022ex31-1_riceacq2.htm Edgar Link pending
f10k2022ex31-2_riceacq2.htm Edgar Link pending
f10k2022ex32-1_riceacq2.htm Edgar Link pending
f10k2022ex32-2_riceacq2.htm Edgar Link pending
f10k2022_riceacq2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
roni-20221231.xsd Edgar Link pending
Show.js Edgar Link pending
roni-20221231_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
roni-20221231_def.xml Edgar Link unprocessable
roni-20221231_lab.xml Edgar Link unprocessable
roni-20221231_pre.xml Edgar Link unprocessable
f10k2022_riceacq2_htm.xml Edgar Link completed